Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®

NCT01696058 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1137

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Tiotropium
DRUG: Placebo matching Olodaterol
DRUG: Tiotropium
DRUG: Olodaterol

Sponsor

Boehringer Ingelheim